Organic Germanium (Ge-132) Reduces Glycative Damage While Maintaining Cellular Stress Signaling, Revealing Limited Coordination Between Biochemical and Cellular Responses.

Organogermanium compounds, particularly carboxyethyl germanium sesquioxide (Ge-132), have been studied for decades because of their diverse biological effects, especially their antioxidant properties. However, the available literature remains fragmented and highly heterogeneous, which limits mechanistic interpretation. Although antiglycative activity has been described at the biochemical level, the downstream transcriptional effects of Ge-132 under glycative stress remain poorly characterized. Here, we combined an evidence-mapping analysis with targeted molecular analysis in a standardized cellular model to examine whether the antiglycative effects of Ge-132 are accompanied by coordinated transcriptional responses. The mapping guided selection of markers associated with glycative stress, including carbonyl detoxification, redox adaptation, autophagy, lysosomal function, and inflammatory signaling. Gene expression analysis revealed limited and selective transcriptional modulation under glycative stress conditions. In parallel, protein analysis showed reduced intracellular accumulation of advanced glycation end products (AGEs) in Ge-132-treated. These findings suggest that reduction of glycative damage can occur without proportional transcriptional activation of stress-response pathways under the conditions tested. However, alternative explanations, such as model constraints, acute exposure duration, or limited gene panel sensitivity, cannot be excluded.